首页>
外国专利>
Anti:asthmatic methyl-xanthine compsns. - synergised with beta-sympathomimetic agents
Anti:asthmatic methyl-xanthine compsns. - synergised with beta-sympathomimetic agents
展开▼
机译:抗:哮喘性甲基黄嘌呤类药物。 -与β-拟交感神经药协同作用
展开▼
页面导航
摘要
著录项
相似文献
摘要
New antiasthmatic compsns. comprise (a) a methylxanthine (e.g. theophylline and aminophylline) and (b) a much lower concn. of =1 beta-sympathomimetic agents salbutamol and terbutaline. Strong bronchodilator effect medicated via cyclic AMP and cyclic GMP. Intracellular cyclic AMP levels are increased by inhibition of phosphodiesterase by methyl xanthines, and by liberation of adenyl cyclase at the levels of the adrenergic bioreceptors by beta-symphathomimetic agents. Synergy is shown. A typical antiasthmatic tablet, dose 2-3 tablets daily, contained 100 mg of aminophylline, 2 mg of terbutaline sulphate and 50 mg of thiazinamium.
展开▼